All Stories

  1. Evolution of Bacterial Yield and Antimicrobial Resistance in Chronic Rhinosinusitis Patients in a Dedicated Sinus Centre
  2. Crossmodal influences on food perception in those with smell and taste disorders: A preliminary study
  3. Minimal requirements for a meaningful workup in patients with smell and taste disorders – A practical guideline based on expert opinion
  4. Persistent Smell and Taste Disorders in the Post‐COVID‐19 Pandemic Era: A Cross‐National Study of Prevalence and Quality of Life in the UK and the USA
  5. COPANOS: use of gabapentin in the management of post-viral parosmia – a double-blind, randomised, placebo-controlled, multi-site trial – study protocol
  6. Comparing Quality of Life in Smell and Taste Disorders With Other Chronic Conditions—A Narrative Review
  7. Acute rhinosinusitis
  8. Rhinosinusitis: Definitions, classification and diagnosis
  9. The Norfolk Smell and Taste Clinic Experience—A Decade of Olfactory and Gustatory Dysfunction
  10. Self-Reported Smell and Taste Disorders in the General Population: A Cross-Sectional Survey in Austria, Germany and Switzerland
  11. Smell and Taste Disorder Impact on Eating Habits: A Cross‐Sectional Observational Study
  12. Chronic rhinosinusitis: a qualitative study of patient and clinician experiences of the MACRO randomised controlled trial of surgical versus medical management
  13. Comparing quality of life in smell and taste disorders with other chronic conditions – a narrative review
  14. Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction
  15. A Cross‐Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction
  16. A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury
  17. The APOLLO Trial: A P roof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Ol factory Dysfunction
  18. Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics
  19. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  20. The need to promote smell health across the globe
  21. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  22. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  23. The need to promote smell health across the globe
  24. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  25. Gustatory dysfunction in dementia and cognitive decline
  26. Olfactory loss and dysfunction in dementia and cognitive decline
  27. A New Approach to Dementia
  28. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  29. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  30. Epidemiology of Cholesteatoma in the UK Biobank
  31. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  32. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  33. Epidemiology of Cholesteatoma in the UK Biobank
  34. Smell Above All: Envisioning Smell-Centred Future Worlds
  35. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  36. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  37. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  38. Obesity and Olfaction
  39. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  40. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  41. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  42. Delivery of Topical Drugs to the Olfactory Cleft
  43. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  44. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  45. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  46. Position paper on olfactory dysfunction: 2023
  47. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  48. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  49. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  50. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  51. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  52. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  53. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  54. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  55. Nose Gym: An Interactive Smell Training Solution
  56. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  57. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  58. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  59. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  60. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  61. The Nose and the Effects of SARS-CoV-2 Pandemic
  62. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  63. The EUFOREA pocket guide for chronic rhinosinusitis
  64. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  65. Investigations and Outcomes for Olfactory Disorders
  66. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  67. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  68. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  69. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  70. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  71. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  72. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  73. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  74. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  75. A Double Blinded Randomised Controlled Trial of Vitamin a Drops to Treat Post-viral Olfactory Loss: Study Protocol for a Proof-of-concept Study for Vitamin a Nasal Drops in Post-viral Olfactory Loss (Apollo)
  76. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  77. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  78. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  79. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  80. International consensus statement on allergy and rhinology: Olfaction
  81. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  82. Interventions for the treatment of persistent post-viral olfactory dysfunction
  83. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  84. Olfaction and CSF Leak
  85. The Growing Burden of Long COVID in the United Kingdom - Insights from the UK Coronavirus Infection Survey
  86. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  87. Increasing incidence of parosmia and phantosmia in patients recovering from COVID-19 smell loss
  88. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  89. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  90. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  91. Barriers to effective health care for patients who have smell or taste disorders
  92. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  93. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  94. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  95. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  96. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  97. Biologics for chronic rhinosinusitis
  98. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  99. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  100. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  101. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  102. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  103. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  104. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  105. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  106. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  107. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  108. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  109. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  110. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  111. Patient Experiences of Postinfectious Olfactory Dysfunction
  112. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  113. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  114. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  115. Comparison of COVID-19 and common cold chemosensory dysfunction
  116. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  117. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  118. Patient Experiences of Post-Infectious Olfactory Dysfunction
  119. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  120. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  121. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  122. Olfactory Loss of Function as a Possible Symptom of COVID-19
  123. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  124. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  125. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  126. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  127. Qualitative Olfactory Disorders: Patient experiences and self-management
  128. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  129. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  130. Parosmia is associated with relevant olfactory recovery after olfactory training
  131. More than smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis
  132. The impact of patients losing their sense of smell
  133. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  134. Post-Viral Olfactory Loss: A Survey of One Hundred and Twenty Patient Experiences
  135. Cholesteatoma and family history: An international survey
  136. Is loss of sense of smell as a diagnostic marker in COVID-19: A Systematic Review and Meta-analysis
  137. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  138. Biologics for chronic rhinosinusitis
  139. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  140. Smoking as a Modifying Factor in Chronic Rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study
  141. Biologics for chronic rhinosinusitis
  142. An unmet need: Patients with smell and taste disorders
  143. 139 Risk of parkinson’s in idiopathic anosmia
  144. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  145. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  146. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  147. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  148. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  149. What is the most appropriate treatment for chronic rhinosinusitis?
  150. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  151. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  152. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  153. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  154. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  155. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  156. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  157. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  158. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  159. Wooden spatula sinusitis following maxillary expansion surgery
  160. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  161. Topical and systemic antifungal therapy for chronic rhinosinusitis
  162. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  163. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  164. Saline irrigation for allergic rhinitis
  165. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  166. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  167. Endonasal Approaches to Maxillary Sinus
  168. The use of nasal sprays and rinses in patients with chronic sinus disease
  169. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  170. Initial assessment in the management of adult epistaxis: systematic review
  171. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  172. Health care usage and quality of life reporting in chronic sinusitis patients
  173. The genetics of cholesteatoma. A systematic review using narrative synthesis
  174. Position paper on olfactory dysfunction
  175. Chronic rhinosinusitis and mood disturbance
  176. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  177. Saline irrigation for allergic rhinitis
  178. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  179. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  180. Position paper on olfactory dysfunction
  181. Chronic rhinosinusitis and mood disturbance
  182. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  183. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  184. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  185. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  186. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  187. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  188. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  189. Topical and systemic antifungal therapy for chronic rhinosinusitis
  190. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  191. SNOT-22 in a control population
  192. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  193. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  194. Genetics of Cholesteatoma Project
  195. Short-course oral steroids alone for chronic rhinosinusitis
  196. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  197. Different types of intranasal steroids for chronic rhinosinusitis
  198. Systemic and topical antibiotics for chronic rhinosinusitis
  199. Saline irrigation for chronic rhinosinusitis
  200. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  201. Chronic rhinosinusitis and mood disturbance
  202. Long term quality of life in patients with fungal sinus disease
  203. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  204. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  205. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  206. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  207. Systemic and topical antibiotics for chronic rhinosinusitis
  208. Saline irrigation for chronic rhinosinusitis
  209. Different types of intranasal steroids for chronic rhinosinusitis
  210. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  211. Short-course oral steroids alone for chronic rhinosinusitis
  212. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  213. The impact of commissioning for rhinosinusitis in England
  214. Investigation of nasal diseases
  215. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  216. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  217. Authors’ response
  218. Hyposmia
  219. Assessing the sense of smell
  220. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  221. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  222. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  223. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  224. The Impact of Olfactory Disorders in the United Kingdom
  225. Chronic Rhinosinusitis and Mood Disturbance
  226. Management of CRSwNPs Surgically
  227. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  228. SNOT-22 in a Control Population
  229. Anatomy and Physiology of the Olfactory and Gustatory Systems
  230. Cerebrospinal Fluid Rhinorrhoea
  231. Ciliary Motility Disorders
  232. Clinical Governance and Audit
  233. Complications of Sinusitis
  234. Endoscopic Sinus Surgery and Complications
  235. Epistaxis
  236. European Position Paper on Rhinosinusitis and Nasal Polyps
  237. Facial Flaps, Scars, and Keloids
  238. Facial Fractures and Swelling
  239. Fungal Sinus Disease
  240. Headache and Facial Pain
  241. Medical Statistics
  242. Microbiology of ENT
  243. Olfactory and Gustatory Disorders
  244. Sinonasal Anatomy and Physiology
  245. Tumours of the Nose and Paranasal Sinuses
  246. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  247. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  248. Unilateral cacosmia: a presentation of maxillary fungal infestation
  249. When mealtime is the most dreaded moment of your day
  250. Pneumatisation of turbinates and paranasal sinuses in children: case report
  251. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  252. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  253. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  254. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  255. A useful tool - systematic checklist for evaluating sinus scans
  256. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  257. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  258. Allergic fungal rhinosinusitis - a new staging system
  259. Allergic fungal rhinosinusitis - a new staging system
  260. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  261. Selecting the Best Approach to the Frontal Sinus
  262. Nanomedicine in otorhinolaryngology: what does the future hold?
  263. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  264. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  265. Tumefactive fibroinflammatory lesion of the frontal sinus
  266. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  267. SUBJECTS AND METHODS
  268. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  269. Proximal Lacrimal Obstruction – A Review
  270. The superosmic phenomenon
  271. The Leicester Olfactometer
  272. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  273. ENT cases seen at a local ‘walk-in centre’: a one year review
  274. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  275. A brief history of olfaction and olfactometry
  276. The superosmic phenomenon
  277. Olfactory clearance: what time is needed in clinical practice?
  278. The Effect of Female Hormone Manipulation on Nasal Physiology
  279. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  280. R152: Olfactory Adaptation and Clearance in Clinical Practice
  281. Bronchiectasis and sino-nasal disease: a review
  282. What is the short term effect of perfumes on olfactory thresholds?
  283. Which variables matter in smell tests in the clinic?
  284. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  285. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  286. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  287. Comparison of Subjective Perception with Objective Measurement of Olfaction
  288. Response to Rachmanidou
  289. A double‐blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on postoperative symptoms
  290. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  291. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  292. Do our Noses Lead Us Away from the Scent?
  293. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  294. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  295. Is there a role for more day-case septal surgery?
  296. Erratum
  297. Canalicular adenoma of the parotid gland
  298. Paediatric retropharyngeal abscess
  299. Which solvent for olfactory testing?
  300. Nasal physiological changes during pregnancy
  301. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  302. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  303. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  304. Subjects and methods
  305. Hyposmia